PATENT CLAIM ANALYSIS

Application Number: 15882767
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "008100"]

Abstract:
The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.

Claim (Index 3):
The pharmaceutical composition of  claim 2 , wherein the cellular factor is isolated from a primary cultured or a cell passaged for at least one, two, three, four, five, six or more passages.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 86.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13220555', '14826613', '14771747', '15623025', '15553505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8441833762858313
- 35 USC 102 Novelty (BERT): 0.6545655143447664
- Combined Prediction Score: 0.8252215900917248
- Mean Citation Score: 544.049848
- Max Citation Score: 818.1908
- Similarity Product: 584.0761514763356

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test